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Abstract 
A library of N-protected dehydroamino acids, namely dehydroalanine, 
dehydroaminobutyric acid and dehydrophenylalanine derivatives, was screened in three 
human cancer cell lines [(lung (A549), gastric (AGS) and neuroblastoma (SH-SY5Y)] 
in order to characterize their toxicological profile and identify new molecules with 
potential anticancer activity. Results showed N-protected dehydrophenylalanine and 
dehydroaminobutyric acid derivatives have no or low toxicity for all tested cell lines. 
The N-protected dehydroalanines exhibit significant toxic effects and the AGS and SH-
SY5Y cells were significantly more vulnerable than A549 cells. Four α,β-
dehydroalanine derivatives, with IC50< 62.5 µM, were selected to investigate the 
pathways by which these compounds promote cell death. All compounds, at their IC50 
concentrations, were able to induce apoptosis in both AGS and SH-SY5Y cell lines. In 
both cell lines, loss of mitochondrial membrane potential (ΔΨm) was found and caspase 
activity was increased, namely endoplasmic reticulum-resident caspase-4 in AGS cells 
and caspase-3/7 in SH-SY5Y. When evaluated in a non-cancer cell line, the molecules 
displayed no to low toxicity, thus suggesting some degree of selectivity for cancer cells. 
The results indicate that α,β-dehydroalanine derivatives can be considered a future 
resource of compounds able to work as anticancer drugs. 
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1. Introduction 
α,β-Dehydroamino acids are non-coded amino acids, characterized by one double bound 
between the Cα and Cβ atoms. α,β-Dehydroamino can be found in peptides isolated from 
bacteria, fungi, marine invertebrates and higher plants (Siodłak, 2015). In general, the 
presence of one or more α,β-dehydroamino acids in a polypeptide chain has strong 
impact, not only on the secondary structure adopted, but also on their biological 
behaviour, including antibacterial, antifungal and antitumor activities (Siodłak, 2015; 
Rudresh et al., 2004;  Gupta and Chauhan, 2011). The current natural α,β-dehydroamino 
acids, detected in thousands of different polypeptides, comprise 37 distinct molecular 
species; however, not all of them can be derived from proteinogenic α,β-amino acids.  
It has been shown that the bioactivity of natural dehydropolypeptides is largely 
dependent on the presence of α,β-dehydroamino acid, as well as on their absolute 
configuration (E/Z isomerism) (Ward et al., 1999; Bonnard et al., 2007). Therefore, α,β-
dehydroamino acids may be produced/incorporated in the polypeptides by highly 
regulated biochemical pathways, preserved during the evolutionary process by the 
adaptive advantages that these natural products should confer to the producing 
organisms. In fact, organisms with different levels of complexity exhibit the 
biosynthetic route of lanthipeptides, where dehydroalanine and dehydroaminobutyric 
acid are produced, in the first step, by a post-translationally dehydration of serine and 
threonine, respectively. Subsequently, the thiol of a Cys is added across the carbon–
carbon double bond of these dehydroamino acids to generate the characteristic 
lanthionine and methyllanthionine thioether-bridged structures (Repka et al. 2017). 
Thus, lanthipeptides are polycyclic peptides belong to a growing family of secondary 
metabolites known as ribosomally synthesized and post-translationally modified 
peptides (Arnison et al. 2013). The broad spectrum of bioactivity and applications found 
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among the known natural compounds containing α,β-dehydroamino acid residues have 
driven the development of methods for the chemical synthesis of dehydroamino acids 
derivatives with selective biological profile for biomedical applications. Since 
dehydroamino acids cannot be incorporated using standard peptide synthesis methods, 
several strategies were developed to pursue that goal. One such strategy, which mimics 
the lanthipeptides biosynthetic pathway, relies on the incorporation of one masked 
amino acid into a polypeptide precursor, followed by their chemoselective dehydration 
(Okeley et al., 2000; Morrison et al., 2015). In our laboratory we developed a simple 
and high yielding procedure to prepare α,β-dehydroamino acid derivatives from β-
hydroxyamino acids by treatment with tert-butylpyrocarbonate (Boc)2O, 4-
dimethylaminopyridine (DMAP), followed by treatment with tetramethylguanidine 
(TMG) (Ferreira et al.,1998; Ferreira et al.,1999; Ferreira et al., 2007). In addition to 
their intrinsic bioactivity, these compounds can be used either as building blocks for the 
synthesis of dehydropolypeptides, as well as substrates to prepare new compounds 
designed to target specific biological targets.  
In the present work, the toxicological profile of nineteen α,β-dehydroamino acids, with 
different N-protecting groups, was characterized using three distinct human cancer cell 
lines and one non-cancer cell line. Cell death mechanisms triggered by the compounds 
with higher toxicity were also investigated, considering the effects on cell viability, 
membrane integrity, cell morphology, caspase activity and mitochondrial membrane 
potential.  
 
2. Material and methods 
2.1. Compounds synthesis and estimation of octanol-water partition coefficients  
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The synthesis of the methyl esters of dehydroamino acids N-protected with benzoyl 
(Bz), 4-nitrobenzoyl [Bz(4-NO2)], 4-nitrobenzyloxycarbonyl [Z(NO2)], 4-
methoxybenzoyl [Bz(OMe)], naphthaloyl (Naph), quinoxalyl (Qnx), 4-toluenesulfonyl 
(Tos), 4-nitrobenzenesulfonyl (Nosyl) and tert-butoxycarbonyl (Boc) was already 
described. (Ferreira et al., 1998; Ferreira et al., 1999; Ferreira et al., 2007; Ferreira et al., 
2001; Ferreira et al., 2003; Ferreira et al., 2008). 
The partition coefficient between water and n-octanol (Log P) of each compound was 
estimated using Molinspiration Cheminformatics software (Molinspiration, Slovensky 
Grob, Slovak Republic, 2017, http://www.molinspiration.com), as a sum of fragment-
based contributions and correction factors, and it is used as quantitative descriptor of 
compound lipophilicity (Cedrón et al., 2005). 
 
2.2.Cell culture 
Three distinct human cancer cell lines were used in this research: gastric carcinoma 
(AGS; Sigma-Aldrich, St. Louis, MO, USA), neuroblastoma (SH-SY5Y; ATCC, 
Barcelona, Spain) and lung carcinoma (A549; ECACC, Porton Down Salisbury, UK). 
The human fetal lung fibroblast cell line MRC-5 (ECACC, Porton Down Salisbury, 
UK) was used as non-cancer cell model. Cell lines were cultured as monolayer at 37 °C 
in a humidified incubator with 5% carbon dioxide. AGS and SH-SY5Y cells were 
grown in glutamine-enriched Dulbecco's Modified Eagle Medium (DMEM), 
supplemented with 1% streptomycin/penicillin and 10% foetal bovine serum (Gibco®), 
while A549 and MRC-5 cells were grown, respectively, in DMEM/F-12 and MEM-
GlutaMax, supplemented with 1% streptomycin/penicillin and 10% foetal bovine 
serum. For subculture, cells were washed with Hank’s buffered salt solution (HBSS), 
treated with 0.25% Trypsin-EDTA solution (Sigma, St. Louis, MO) for 3 min at 37 °C, 
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resuspended in 5 mL of culture medium and centrifuged at 390 g for 4 min. The 
supernatant was removed and the cell pellet was resuspended in culture medium. 
Subculture ratio was usually 1:3 for SH-SY5Y cells and 1:5 for ASG and A549 cells. 
Cell passages were kept low for all cell lines, with a maximum of 12 passages. 
 
2.3.Cell viability and membrane integrity 
Cell viability was evaluated using the MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium] reduction assay, while membrane integrity was assessed by the 
lactate dehydrogenase (LDH) release assay, as previously described [Pereira et al., 
2014]. Briefly, cells were seeded in 96-well microplates at a density of 15,000, 30,000, 
10,000 and 20,000 cells/well for AGS, SH-SY5Y, A549 and MRC-5 cells, respectively, 
and placed at 37 °C in a CO2 incubator. After 24 h cells reached 70–80% confluence 
and were incubated with the dehydroamino acid derivatives at different concentrations 
(up to 62.5 µM) or with DMSO (vehicle), at 37 °C for 24 h, after which the MTT and 
LDH assays were conducted, as described below. 
MTT (0.5 mg/mL final concentration) was added to each well and the plate was 
incubated for 2 h, at 37 °C. The formazan was dissolved with 200 µL of a 
DMSO:isopropanol mixture (3:1, V:V) and quantified spectrophotometrically at 560 nm 
using a microplate reader (Multiscan GO, Thermo Scientific). Results were expressed as 
percentage of control and IC50 values were determined from the plots of cell viability 
data against α,β-dehydroamino acid derivatives concentration. 
LDH activity was evaluated spectrophotometrically following NADH oxidation at 340 
nm during 3 min, using a microplate reader (Multiscan GO, Thermo Scientific). The 
reaction was conducted using 50 µL of cell-free supernatant of extracellular medium or 
25 µL of supernatant of cell lysates into phosphate buffer (50 mM KH2PO4, pH 7.4), 
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supplemented with 10 µM pyruvate and 300 μM of NADH. LDH release in each well 
was determined by the ratio between LDH activity in extracellular medium and LDH 
activity of controls treated with lysis solution (1% Triton X-100 in 10 mM phosphate 
buffer, pH = 7.2). Results were expressed as fold increase relative to DMSO-treated 
cells (vehicle-treated controls). 
 
2.4.Cell lipid extraction, phospholipids and cholesterol quantification  
Total lipids of A549, AGS, SH-SY5Y and MRC-5 cells were extracted by using a 
double extraction procedure with a solvent combination of methanol/chloroform/water 
at final proportions of 2:1:0.8 (v/v/v), as previously described (Monteiro-Cardoso et al., 
2014). Briefly, a volume of cell suspension corresponding to 2 mg of protein was 
reconstituted in 0.8 mL aqueous buffer, mixed with 2 mL methanol and 1 mL 
chloroform and then centrifuged at 2,000 g for 5 min at 4 °C. Supernatant was collected 
and an additional volume of 1 mL chloroform and 2 mL water were added to 
supernatant following vigorous mixing. Samples were centrifuged at 2000 g for 5 min at 
4◦C, in order to obtain a two-phase system: an aqueous top phase and an organic bottom 
phase from which lipids were collected. The pellet obtained in the first centrifugation 
was used to perform lipid re-extraction. The extracts were dried in a nitrogen stream and 
used to quantify the cholesterol and phospholipid contents. 
Cholesterol of total lipid extracts was quantified according to Liebermann-Burchard 
procedures and phospholipids by phosphorus assay after acid hydrolyses, as previously 
described (Monteiro-Cardoso et al., 2014). 
 
2.5.Caspases assays 
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Caspase-3/7 protease activity was evaluated fluorometrically, by measuring the ability 
of cell lysates to cleave the proluminescent DEVD peptide-rhodamine 110 substrate (Z-
DEVD)2-R110;Caspase-Glo®kit, Promega, Madison USA), as suggested by the 
manufacturer. AGS and SH-SY5Y were seeded in 96-well white plates, as previously 
described for MTT and LDH. After 24 h cells were incubated with dehydroamino acid 
derivatives at IC50 concentrations, or with either 250 nM staurosporine (positive 
control) or vehicle (DMSO), for 8 h, at 37 °C. After this period, 50% of cell medium 
was removed and similar volume of caspase-3/7 substrate was added. Plates were 
incubated in a microplate reader (Synergy H1, BioTek) and the luminescent signal was 
measured at different time points, up to 120 min. Results were expressed as fold 
increase in luminescence relative to DMSO-treated cells (vehicle-treated controls). 
Caspase-4 activity was assessed by the ability of cell lysates to cleave specific Z-AFC 
peptide substrate (Innovagen, Lund, Sweden) and to produce a fluorescent compound 
with emission at 505 nm under excitation at 400 nm. AGS and SH-SY5Y cells were 
seeded in 96-well black plates, as previously described for MTT and LDH assays, and 
allowed to attach for 24 h. Afterwards, cells were incubated with α,β-dehydroamino 
acid derivatives at IC50 concentrations, or with 1 mM palmitic acid (positive control) or 
vehicle (DMSO), for 8 h, at 37 °C. Supernatants were removed, caspase-4 substrate (50 
µM) was added and plates were incubated for 150 min, at 37 °C. Fluorescence 
(excitation: 400 nm; emission: 505 nm) was determined in a microplate reader (Synergy 
H1, BioTek) at different time points, up to 120 min. Results were expressed as fold 
increase relative to DMSO-treated cells (controls). 
For the assessment of caspase-9 activity, AGS and SH-SY5Y cells were seeded in 6-
well plates at a cell density of 75,000 and 550,000 cells/well, respectively, and placed at 
37 °C in a CO2 incubator. After 24 h cells were incubated with α,β-dehydroamino acid 
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derivatives at IC50 concentrations, or with either 250 nM staurosporine (positive 
control) or vehicle (DMSO), for 8 h, at 37 °C. The culture medium was then removed 
and cells were washed with HBSS, treated with 0.25% Trypsin-EDTA solution and 
centrifuged at 390 g, for 4 min, to collect the cells as pellet. Afterwards, cells were lysed 
with a lysis buffer (25 mM Hepes, 5 mM EDTA, 1 mM EGTA, 5 mM MgCl2, 5 mM 
DTT, pH 7.4, 1% of protease inhibitor cocktail) and subjected to centrifugation at 
14 500 g for 15 min, at 4 °C. Supernatants (mitochondria-free cytosolic fractions) were 
collected and the protein concentration was determined by the Bradford method 
(Kruger, 1994). In order to measure caspase-9 activity, aliquots of mitochondria-free 
cytosolic fractions containing 50 µg of protein were reconstituted in 150 µL of caspase-
9 buffer (25 mM Hepes, pH 7.5, 5 mM DTT, 0.1% CHAPS, and 10% sucrose) 
supplemented with 50 μM of fluorometric AC-LGHA-AMC caspase-9 substrate (CPC 
Scientific, CA, USA). Fluorescence was measured in a fluorescent microplate reader 
(Synergy H1, BioTek) working at an excitation wavelength of 405 nm and an emission 
wavelength of 535 nm, at different time points, up to 180 min. Results were expressed 
as fold increase relative to DMSO-treated cells (controls). 
 
2.6.Cell morphology 
AGS and SH-SY5Y cells were seeded on coverslips and placed at 37 °C in a CO2 
incubator. After 24 h, cells were treated with dehydroalanine derivatives at IC50 
concentrations and incubated for 8 h. After this period cells were fixed on coverslips 
with cold methanol, stained with Giemsa stain and their morphological features were 
examined under a light microscope (Nikon Eclipse Ci). 
 
2.7. JC-1 Mitochondrial Membrane Potential Assay 
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AGS and SH-SY5Y cells were seeded in 96-well black plates according to conditions 
described above for MTT and the Caspase-3/7 assays. Cells were incubated with JC-1 
(5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl benzimidazol carbocyanine iodide; Abcam Inc., 
Cambridge, MA, USA) (7 µM) for 20 minutes, followed by 3 washes with HBSS. For 
the quantification of mitochondrial membrane potential (ΔΨm), the plate was read using 
fluorescence microplate reader (Synergy H1, BioTek)) with excitation/emission settings 
at 485/535 and 560/595 nm, respectively (da Silva et al., 2017). Cells in HBSS were 
used as negative control and cells treated with 250 µM FCCP, for 30 minutes prior the 
JC1-addition, were used as a positive control. The ratio of JC-1 aggregate to monomer 
(the 595:535 ratio) was calculated and a decrease in this ratio was interpreted as ΔΨm 
depolarization. 
 
2.8.Data analysis 
Statistical analysis was carried out by using GraphPad Prism 5. The level of 
significance between different treatment groups relative to control was determined by 
one-way analysis of variance (ANOVA), followed by Bonferroni test for between-group 
comparison. P < 0.05 was considered statistically significant. All data were presented as 
mean ± standard error of the mean (SEM) of three independent experiments, each one 
performed in triplicate.  
 
3. Results and discussion  
This study covered seven N-substituted α,β-dehydrophenylalanines, seven α,β-
dehydroaminobutyric acid derivatives and five α,β-dehydroalanines, which were 
prepared using a previously described methodology (Ferreira et al.,1998; Ferreira et 
al.,1999; Ferreira et al., 2007).  
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As shown in Table 1, all α,β-dehydroaminoacids derivatives were N- and C-protected. 
In all cases the C-protection was a methyl ester. Within each group of α,β-
dehydroamino acids, the molecular diversity emerges from the chemical structures of 
the N-protecting group. Nine different N-protecting groups (one aliphatic and eight with 
aromatic structures) were used. The library of compound depicted in Table 1 allowed us 
to study i) the role of the N-protecting group on the biological behaviour within each 
group of α,β-dehydroamino acid derivatives (vertical comparisons), and ii) the impact 
of a specific N-protecting group on the biological properties of different families of α,β-
dehydroamino acids (horizontal comparisons). 
The presence of a α,β-double bond in the dehydroamino acid residues allows, in the 
case of dehydrophenylalanine and dehydroaminobutyric acid, the occurrence of E and Z 
isomers. Since the molecular configuration has high biological relevance, the selectivity 
of the synthesis methodology adopted should be taken into account in order to discuss 
the bioactivity of dehydroaminobutyric acid and dehydrophenylalanine derivatives. The 
synthesis of these compounds was carried out using a procedure that is stereoselective 
for the Z-isomer (Ferreira et al., 1998; Ferreira et al., 1999; Ferreira et al., 2007). The 
possible coplanarity of the α,β-double bond with the amide groups, enabling π-electron 
conjugation that, in some compounds, may be extended up to the aromatic ring of the N-
protecting group, together with the chemical nature of the N-protecting group may 
dictate a putative impact on the dehydroamino acids chemical and biological behaviour, 
including on their bioavailability and lipophilicity.  
In a first approach considering the compound lipophilicity, the partition coefficient 
between water and n-octanol (Po/w) of each compound was estimated as a sum of 
fragment-based contributions and correction factors by numerical methods 
(Molinspiration Cheminformatics software, 2017). The values, expressed as a logarithm 
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Log P, are presented in Table 1. According to the predicted Log P values, the affinity of 
all dehydroamino acid derivatives for octanol phase is significantly higher (between one 
and four orders of magnitude) than for aqueous phase, suggesting their preferential 
accumulation into the lipid phase of biological systems. It is important to highlight that 
the log P prediction approach used herein has the potential to process practically all 
types of organic molecule, as it was validated with 12202 molecules and yielded a good 
correlation value (R2 =0.92) between the calculated and the experimentally determined 
values (http://www.molinspiration.com/services/logp.html). Additionally, it is 
considered by many researches as a robust methodology to predict realistic Log P 
values, which are used as quantitative descriptors of compound lipophilicity (Cedrón et 
al., 2005; Mannhold et al., 2009). Thus, data in Table 1 also show that for the same N-
protecting group, the lipophilicity of dehydroamino acid derivatives follows the order 
dehydrophenylalanine > dehydroaminobutyric acid > dehydroalanine, as expected. 
Considering the partition coefficient values of all dehrydroamino acid derivatives, the 
plasma membrane (the first physiological barrier encountered by xenobiotics) and the 
membranes of intracellular compartments (e.g. mitochondria) should be the main targets 
for the putative toxicity of these compounds.  
 
3.1.Cytotoxicity profile of α,β-dehydroaminoacid derivatives  
Compounds were screened for their potential as cytotoxicity in three distinct human 
cancer cell lines, namely A549, AGS and SH-SY5Y cells. These cancer cells were 
chosen since they are well-established cell models for three human malignant tumour 
types with high incidence and mortality worldwide (Global Burden of Disease Cancer 
Collaboration 2016). A549 cell line is a model of non-small cell lung cancer, 
characterized by a high aggressive phenotype and high resistance to chemotherapeutic 
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drugs (Lopez-Ayllon et al., 2014). AGS cells are representative of human intestinal-type 
gastric cancer that also exhibit an evolution pattern of resistance to chemotherapeutic 
drugs (Jang et al., 2017). SH-SY5Y cells, typically used as a model system to study 
neuronal development and neurodegenerative diseases, are representative of 
neuroblastoma tumours that normally are sensitive to chemotherapy, even in advanced 
stages of disease (Zhang et al., 2016). Thus, a broad spectrum of cancer cell phenotypes, 
with distinct susceptibility to chemotherapeutic drugs, were used to assess the 
anticancer activity of the α,β-dehydroamino acid derivatives. Our strategy to screen the 
cytotoxic activity of these compounds involved, initially, the evaluation of the effects of 
increasing concentrations (15.625, 31.25 and 62.5 µM) of each dehydroamino acid 
derivative on the cell viability and plasma membrane integrity of the selected human 
cancer cell lines. When the effects of those concentrations allowed to predict that a 
given compound had an IC50 smaller than 62.5 µM, additional concentrations of the 
compound were assessed in order to determine the IC50 with higher accuracy.  
Figure 1 shows the effects of increasing concentrations of the dehydrophenylalanine 
derivatives on the viability of A549, AGS and SH-SY5Y cells, after a 24 h incubation 
period, evaluated by the MTT reduction assay. Dehydrophenylalanine derivatives have 
limited toxic effects or do not alter the cell viability of these human cancer cell lines. 
However, data on Figure 1 also revealed that the toxicity of dehydrophenylalanine 
derivatives depends on the human cancer cell line and on the chemical nature of the N-
protecting group. A549 cell line is the most sensitive to this type of compounds, since at 
the highest concentration used (62.5 µM) the dehydrophenylalanine derivatives with an 
aromatic moiety in the N-protecting group significantly decreased cell viability. Toxic 
effects were detected for the methyl esters of N-nitrobenzoyl and N-
nitrobenzyloxycarbonyldehydrophenylalanine (Phe2 and Phe3, respectively) at 31.25 
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µM. Differently, SH-SY5Y cells were affected by the methyl ester of N-(tert-
butyloxycarbonyl)-dehydrophenylalanine (Phe9), but not by those derivatives having an 
aromatic moiety in the N-protecting group.  
AGS cells viability is significantly reduced by four dehydrophenylalanine derivatives 
with aromatic protecting groups (Phe2, Phe3, Phe5 and Phe7), the most toxic being the 
derivative with the toluenesulfonyl group (Tos). The effect of dehydrophenylalanine 
derivatives on the LDH released into cell culture medium of A549, AGS and SH-SY5Y 
cells was studied, after 24 h incubation (Figure S1 – supplementary material). No 
compound caused any detectable effects on the extracellular levels of LDH at the 
concentration range tested. These data indicate that reduction of cell viability detected 
by MTT assay is not associated with permeabilization of plasma membrane, and that 
cytotoxicity of dehydrophenylalanine derivatives does not involve necrosis. 
The effects of increasing concentrations of dehydroaminobutyric acid derivatives on the 
viability of A549, AGS and SH-SY5Y cells, evaluated by MTT assay and by the 
activity of LDH released into cell culture media, are shown in Figures 2 and S2, 
respectively. Considering the MTT assay, the dehydroaminobutyric acids present low 
toxicity for the three human cancer cell lines within the concentration range tested. Data 
of Figure 2 also suggest that A549 cells are the most resistant, SH-SY5Y cell line being 
the most sensitive to the effects of dehydroaminobutyric acid derivatives. All 
compounds were able to promote a significant decrease of the viability of 
neuroblastoma cells at 62.5 µM, however the reduction of cell viability never exceeded 
30%. Considering the biological role of the N-group on this type of compounds, it is 
evident that effects are cell type-dependent. For example, the methyl ester of N-
benzoyldehydroaminobutyric acid (Abu1) induced toxicity in A549 and SH-SY5Y cells 
without apparent effects on AGS cells, while the methyl ester of N-
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quinoxalyldehydroaminobutyric acid (Abu6) affected AGS and SH-SY5Y cells, but not 
A549 cells. 
Figure 3 shows the effects of increasing concentrations of the dehydroalanine 
derivatives on the viability of the three cell lines, after a 24 h incubation, evaluated by 
the MTT reduction assay. From the overall data depicted in Figure 3, three remarkable 
features emerge: i) in the concentration range up to 62.5 µM, all dehydroalanine 
derivatives significantly decreased the viability of the three human cancer cell lines; ii) 
for all cancer cell-types used, the cytotoxicity of this group of compounds is 
significantly higher than that detected for the compounds with the same N-protecting 
group, but belonging to the others dehydroamino acid derivatives; iii) A549 cell line is 
significantly less sensitive to the effects of dehydroalanine derivatives than AGS and 
SH-SY5Y cell lines. 
Additional concentrations of each dehydroalanine derivative were tested in AGS and 
SH-SY5Y cells, in order to more accurately assess the IC50 values. Considering the IC50 
values presented in Table 2, the N-protecting group has a strong impact on the 
cytotoxicity of dehydroalanine derivatives. For example, the methyl ester of 
nitrobenzoyldehydroalanine (Ala2), which has a nitro group in the aromatic ring of the 
N-acyl group, decreases the IC50 from values higher than 62.5 µM to 29.4 µM in AGS 
cells and to 23.9 µM in SH-SY5Y cells, when compared with the methyl ester of N-
benzoyldehydroalanine (Ala1).  
The toxicity of dehydroalanine derivatives in AGS cells follows the order Ala1 < Ala3 
< Ala6 <Ala5 < Ala2, while in SH-SY5Y cells Ala5 switches its position with Ala2 
(Ala1 < Ala3 < Ala6 < Ala2< Ala5).  Therefore, nitrobenzoyldehydroalanine (Ala2) 
(IC50 of 29.4 µM for AGS and 23.9 µM for SH-SY5Y) and naphthaloyldehydroalanine 
(Ala5) (IC50 of 36.8 µM for AGS and 21.0 µM for SH-SY5Y) are the most toxic 
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compounds, SH-SY5Y cells being more sensitive to the toxic effects of dehydroalanine 
derivatives than AGS cells (Fig. 3, table 2). 
In order to access selectivity of the molecules towards cancer cells, we have also 
evaluated the effect of dehydroalanine derivatives on the viability of MRC-5 cells, a 
non-tumorigenic human lung fibroblast cell line (Figure 4, Table 2). Results show that 
the MRC-5 cell line, with lower lipid content, is significantly less affected by 
dehydroalanine derivatives than all cancer cell lines. Only the Ala6 compound exhibits 
similar toxicity on MRC-5 and A549 cell lines.   
Taking into account the structural features of each compound and their toxicity, the 
capability of the N-protecting group to polarize the α,β-double bond seems to be the 
main factor determining the toxicological profile of α,β-dehydroalanine derivatives. 
Dehydroalanine derivatives displaying an acyl protecting group (Ala1, Ala2 e Ala5) are 
considerably more toxic when compared with other protecting groups. Considering the 
series of compounds N-protected with benzoyl, 4-nitrobenzoyl and 4-
nitrobenziloxycarbonyl groups (Ala1, Ala2 and Ala3), the dehydroalanine derivative 
with the most electron withdrawing group attached to nitrogen atom (4-nitrobenzoyl 
group, Ala 2) is the most toxic, which could be attributed to the polarization of the α,β-
double bond through an extended conjugated system with the N-protecting group. Also, 
the increase of toxicity is attained with minor effects on lipophilicity. Conjugation with 
the N-protecting group has an important effect on the toxicity, since the dehydroalanine 
with the 4-nitrobenzyloxycarbonyl group (Ala3) with one sp3 carbon atom that breaks 
the conjugation between the aromatic ring and the amino group is significantly less 
toxic than Ala2. Regarding dehydroalanines with naphthaloyl (Ala5) and quinoxaloyl 
(Ala6) groups, they have different effects, the quinoxaloyl derivative being less toxic. 
Although both groups allow extended conjugation, the quinoxalyl ring is more electron 
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withdrawing than naphthaloyl, which increases the toxicological potential of Ala6. 
However, the ability of Ala6 to accumulate into the lipid phase of the biological 
membranes is much lower than of naphthaloyldehydroalanine (Log P (Ala6) = 0.52, 
Log P (Ala5) = 2.92). These results suggest that the noxious effects of dehydroalanine 
derivatives are dependent of both effective membrane concentration of compound 
(proportional to Log P) and from the ability of the N-protecting group to polarize the 
α,β-double bond. In fact, the higher toxicity of naphthaloyldehydroalanine (Ala5) when 
compared with benzoyldehydroalanine (Ala1) should also emerge from the greater 
lipophilic character conferred by naphthalene. Moreover, the susceptibility of these 
cancer (A549, AGS, SH-SY5Y) and non-cancer (MRC-5) cells to the toxic effects of 
the N-protect dehydroalanine derivatives seems to be directly correlated with their 
relative content in membrane lipids (Table 2). 
In order to investigate whether the loss of cell viability detected by MTT reduction 
assay is connected with cell death by necrosis, the activity of LDH released into the 
culture medium of A549, AGS and SH-SY5Y cells was evaluated (Figure S3 
supplementary material). In the concentration range tested, the incubation of A549 and 
AGS cells with dehydroalanine derivatives did not promote any detectable effect on the 
extracellular levels of LDH, indicating that the toxic effects detected by MTT assay in 
these cells are not associated with plasma membrane damage. In SH-SY5Y cells, 
benzoyldehydroalanine (Ala1) and 4-nitrobenzyloxycarbonyldehydroalanine (Ala3) did 
not affect extracellular LDH activity for all concentrations tested. The same did not 
happen with concentrations ≥31.25 µM of the compounds with 4-nitrobenzoyl (Ala2) 
and naphthaloyl (Ala5) groups, or with the highest concentration tested (62.5 µM) of 
quinoxalyldehydroalanine (Ala6). Therefore, at higher concentrations, Ala2, Ala5 and 
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Ala6 may induce SH-SY5Y cell death by necrosis, which involves rupture of plasma 
membrane and increased extracellular LDH activity. 
Studies with Ala2, Ala3, Ala5 and Ala6 were extended to gather more information 
about the cell death pathways triggered by these dehydroalanine derivatives at low 
concentrations, since they exhibit IC50< 62.5 µM for both AGS and SH-SY5Y cells. 
 
3.2. α,β-Dehydroalanine derivatives trigger morphological changes in cells, 
caspases activation and mitochondrial membrane depolarization 
In order to elucidate the mechanism responsible for the cell death, morphological 
assessment of cells treated with α,β-dehydroalanine derivatives was carried out.  
AGS and SH-SY5Y cells were treated with Ala2 and Ala5 at the IC50 concentration for 
8 h, stained with Giemsa stain and examined under light microscope (Fig. 5). Incubation 
of AGS and SH-SY5Y cells with Ala2 (Fig 5b, e) or with Ala5 (Fig. 5c, f) shows the 
advent of chromatin condensation, pyknotic nuclei and, in some cases, chromatin 
fragmentation. These morphological traits are compatible with a process of programmed 
cell death, reason for which apoptosis was evaluated in subsequent experiments. 
Caspases are a family of cysteine dependent aspartate driven proteases that play a key 
role in the metabolic pathways and signalling networks used by cells to regulate cell 
death and inflammation, which are fundamental to preserve the functional homeostatic 
balance of multicellular organisms (McIlwain et al., 2013). Caspases involved in 
apoptosis are normally sorted as initiator caspases (caspase-8 and -9, associated with 
extrinsic and intrinsic pathways, respectively) and executioner caspases (caspase-3, -6 
and -7) that are the effective players of the characteristic morphological events of 
apoptosis (Pereira et al., 2014). Caspase-4, initially associated with the regulation of the 
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inflammatory process, is now also considered to be a key player of apoptosis triggered 
by endoplasmic reticulum stress (Pereira et al. 2015; Bian et al., 2009). 
In order to evaluate whether the selected dehydroalanine derivatives are able to induce 
cancer cell apoptosis, the proteolytic cleavage activity of caspases-3/7, caspases-9 and 
caspase-4 was assessed in AGS and SH-SY5Y cell lines, 8 h after cell incubation with 
compounds at IC50 concentrations (Fig. 6). 
As shown in Figure 6a and 5d, the selected dehydroalanine derivatives promote a 
significant increase of the activity of caspases-3/7 in both AGS and SH-SY5Y cell lines. 
In AGS cells, the effects on caspase 3/7 activity are similar for all dehydroalanine 
derivatives. Thus, the intensity of the effects in neuroblastoma cells seems to be 
dependent of the N-protecting group, following the order Ala2 > Ala5 > Ala6 ≥ Ala3. 
Regarding the initiator caspase of the intrinsic or mitochondrial pathway, data on Figure 
6b show that the proteolytic cleavage activity of caspase-9 in AGS cells incubated with 
the compounds is higher than in control cells. However, the differences did not reach 
statistical significance, suggesting that the apoptotic running detected in AGS cells by 
the increased caspases-3/7 activity did not proceed from caspase-9 activation, usually 
associated to the mitochondrial pathway of apoptosis. In fact, Ala2, Ala5 and Ala6 were 
able to promote a significant increase of caspase-4 proteolytic cleavage activity, a 
caspase connected not only with inflammasome activation, but also with programmed 
cell death via endoplasmic reticulum-stress pathway (Pereira et al., 2015), as shown in 
Figure 6c. Thus, the endoplasmic reticulum may be the main toxicological target of 
dehydroalanine derivatives in intestinal-type gastric cancer cells. 
On the other hand, in SH-SY5Y cells dehydroalanine derivatives did not promote any 
detectable effects on the activity of caspase-4 (Fig. 6f). Furthermore, only compound 
Ala2 was able to induce a significant increase of proteolytic cleavage activity of 
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caspase-9 (Fig. 6e). Since the activation of upstream caspase-9 leads to the proteolytic 
activation of the downstream or effector caspases-3/7 (McIlwain et al., 2013), Ala2 may 
induce SH-SY5Y cells apoptosis through the mitochondrial pathway. In relation to cell 
death pathways triggered by Ala3, Ala5 and Ala6 dehydroalanine derivatives in SH-
SY5Y cells, our data did not support any preferential pathway. However, it is important 
to stress that during apoptotic cell death, caspases are sequentially activated in a self-
amplifying cascade and the duration of an apoptotic run, dependent of cell type, was 
estimated to change between 6 and 24 h [Gravrieli et al., 1992].  
Considering that the loss of mitochondrial membrane potential (ΔΨm) is a typical 
feature of apoptotic cells (Zamzami and Kroemer, 2001), the influence of Ala2, Ala3, 
Ala5 and Ala6 on ΔΨm of AGS and SH-SY5Y cells was evaluated (Figure 7). The ratio 
of the fluorescent probe JC-1 aggregate to monomer is directly proportional to ΔΨm, 
since mitochondrial accumulation of the membrane-permeable cationic probe is 
governed by Nernst equation. Dehydroalanine derivatives promoted a significant 
decrease of ΔΨm in both AGS and SH-SY5Y cell lines, being Ala6 the most efficient 
for both cell lines. Thus, the effects of these molecules upon ΔΨm are in agreement 
with the results described before in morphological assessment and caspases activity. 
Nevertheless, the activation of death receptors in plasma membrane (extrinsic pathway) 
and cell autophagy are other possibilities not investigated in the present work.  
 
4. Conclusions 
The present work describes for the first time the biological activity of α,β-
dehydroamino acid derivatives on three human cancer cell lines, representatives from 
lung (A549), gastric (AGS) and neuroblastoma (SH-SY5Y) tumours. Chemical 
screening revealed four α,β-dehydroalanine derivatives with significant cytotoxic 
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effects  (IC50< 62.5 µM) on both AGS and SH-SY5Y cells. The analysis of structure-
activity relationships suggests the lipophilic character of dehydroalanine derivatives 
associated with the electron withdrawing effect of the N-protecting group are the main 
factor determining the toxicity of α,β-dehydroalanine derivatives. Additionally, the 
selected compounds trigger a process of programmed cell death compatible with 
apoptosis, putatively endoplasmic reticulum-dependent in the case of AGS cells and 
mitochondria-dependent in SH-SY5Y cells. Considering that many pharmacological 
drugs used in cancer treatment have the induction of apoptosis and/or cell cycle arrest as 
a primary goal (Makin and Dive, 2001; Wong, 2001), α,β-dehydroalanine derivatives 
(e.g. Ala2 and Ala5) that are able to kill both AGS and SH-SY5Y cells (IC50< 30 µM) 
through the induction of apoptosis may be potential resources for coping with human 
intestinal-type gastric cancer and neuroblastoma tumours. 
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Figure S2. Activity of LDH released into culture medium of A549, AGS and SH-SY5Y 
cells, incubated for 24 h, with increasing concentrations of α,β-dehydro-2-aminobutyric 
acid derivatives. 
Figure S3. Activity of LDH released into culture medium of A549, AGS and SH-SY5Y 
cells, incubated for 24 h with increasing concentrations of α,β-dehydroalanine 
derivatives.  
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Table 1.  Library of N-protected α,β-dehydroamino acids derivatives used in the 
present study. General structure, designation (Nº), structure of the N-substituent group 
(R) and logarithm of the partition coefficient between water and n-octanol (Log P). 
 
α,β-dehydrophenylalanine derivatives α,β-dehydroaminobutyric acid derivatives α,β-dehydroalanine 
 derivatives 
 
Nº        (R) Structure/ name                Log P 
 
 
Nº        (R) Structure/name                 Log P 
 
 
Nº               (R) Structure/name          Log P 
Phe1 
 
Bz-ΔPhe-OMe 
3.45 Abu1 
 
Bz-ΔAbu-OMe 
2.00 Ala1 
 
 
BzΔAla-OMe 
1.75 
Phe2 
 
Bz(NO2)-ΔPhe-OMe 
3.41    Ala2 
 
Bz(NO2)-ΔAla-OMe 
1.71 
Phe3 
 
Z(NO2)-ΔPhe-OMe 
3.82  Abu3 
 
Z(NO2)-ΔAbu-OMe 
2.37 Ala3 
 
Z(NO2)ΔAla-OMe 
2.12 
Phe4 
 
Bz(OMe)-ΔPhe-OMe 
3.41 
 
Abu4 
 
 
Bz(OMe)ΔAbu-OMe 
2.05   
 
 
Phe5 
 
Naph-ΔPhe-OMe 
4.64 Abu5 
 
Naph-ΔAbu-OMe 
3.18 Ala5 
 
Naph-ΔAla-OMe 
2.93 
 
  
Abu6 
 
Qnx-ΔAbu-OMe 
2.03 Ala6 
 
Qnx-ΔAla-OMe 
0.52 
Phe7 
 
Tos-ΔPhe-OMe 
3.78 Abu7 
 
Tos-ΔAbu-OMe 
2.32    
 
  
Abu8 
 
Nosil-ΔAbu-OMe 
1.83    
Phe9 
 
Boc-ΔPhe-OMe 
3.45       
 
   
   
  
   
  
 
O
 
O
 
O
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Table 2. Membrane lipid parameters of total lipid extract obtained from  cancer (A549, AGS 
and SH-SY5Y) and non-cancer (MRC-5) cells; and IC50 values of the N-protected α,β-
dehydroalanine derivatives assessed in A549, AGS, SH-SY5Y and MRC-5 cell lines by MTT 
assay. 
 A549 AGS SH-SY5Y MRC-5 
Phospholipid content 
(nmol/ mg of protein) 269.2±19.6 352.8±32.6 391.7±36.7 155.7±14.8 
Cholesterol content  
(nmoles/mg of 
protein) 
67.8±6.2 108.9±27.7 118.9±37.6 52.6±4.6 
α,β-dehydroalanine 
derivatives / Nº 
IC50 (µM) IC50 (µM) IC50 (µM) IC50 (µM) 
Ala1 >62.5 >62.5 >62.5 >62.5 
Ala2 >62.5 29.4 23.9 >62.5 
Ala3 >62.5 60.3 62.3 >62.5 
Ala5 >62.5 36.8 21.0 >62.5 
Ala6 >62.5 54.6 42.4 >62.5 
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Legend to the Figures 
 
Figure 1. Cytotoxicity of α,β-dehydrophenylalanine derivatives in A549, AGS and SH-
SY5Y cells. Cell viability was assessed by the MTT reduction assay after a 24 h 
incubation period, as described in Materials and Methods. Results are expressed as 
percentage of control (cells treated with vehicle) and presented as mean ± standard error 
of mean (SEM) of, at least, three independent experiments, each one performed in 
triplicate. Comparisons relative to the control were performed using one-way ANOVA 
with Bonferroni as post-test (*p < 0.05; **p < 0.01; ***p < 0.001).  
 
Figure 2. Cytotoxicity of α,β-dehydroaminobutyric acid derivatives in A549, AGS and 
SH-SY5Y cells. Cell viability was assessed by the MTT reduction assay after 24 h 
incubation period, as described in Materials and Methods. Results are expressed as 
percentage of control (cells treated with vehicle) and presented as mean ± standard error 
of mean (SEM) of, at least, three independent experiments, each one performed in 
triplicate. Comparisons relative to the control were performed using one-way ANOVA 
with Bonferroni as post-test (*p < 0.05; **p < 0.01; ***p < 0.001).  
 
Figure 3. Cytotoxicity of α,β-dehydroalanine derivatives in A549, AGS and SH-SY5Y 
cells. Cell viability was assessed by the MTT reduction assay after 24 h incubation 
period, as described in Materials and Methods. Results are expressed as percentage of 
control (cells treated with vehicle) and presented as mean ± standard error of mean 
(SEM) of, at least, three independent experiments, each one performed in triplicate. 
Comparisons relative to the control were performed using one-way ANOVA with 
Bonferroni as post-test (*p < 0.05; **p < 0.01; ***p < 0.001).  
 
Figure 4. Cytotoxicity of α,β-dehydroalanine derivatives in MRC-5 cells. Cell viability 
was assessed by the MTT reduction assay after 24 h incubation period, as described in 
Materials and Methods. Results are expressed as percentage of control (cells treated 
with vehicle) and presented as mean ± standard error of mean (SEM) of, at least, three 
independent experiments, each one performed in triplicate. Comparisons relative to the 
control were performed using one-way ANOVA with Bonferroni as post-test (***p < 
0.001).  
30 
 
Figure 5. Morphological assessment of Giemsa stained AGS (a, b, c) and SH-SY5Y (d, 
e, f) cells, evaluated by light microscopy, without (a, d) and after treatment with Ala2 
(b, e) or Ala5 (c, f) α,β-dehydroalanine derivatives, at IC50 concentrations, for 8 h. 
Giemsa staining shows chromatin condensation (green arrows) and fragmentation (red 
arrows). 
 
Figure 6. Effect of α,β-dehydroalanine derivatives (Ala2, Ala3, Ala5 and Ala6) at IC50 
concentrations on the proteolytic cleavage activity of caspases-3/7 (a, d), caspase-9 (b, 
e) and caspase-4 (c, f) of AGS (a, b, c) and SH-SY5Y cells (d, e, f). Results are 
expressed as fold increase relative to DMSO-treated cells (control) and presented as 
mean ± standard error of mean (SEM) of three independent experiments, each one 
performed in duplicate. Staurosporine (250 nM) was used as positive control for 
caspase-3/7 and caspase-9 and palmitic acid (1 mM) for caspase-4. Comparisons 
relative to the control were performed using one-way ANOVA with Bonferroni as post-
test (*p < 0.05; **p < 0.01; ***p < 0.001).  
 
Figure 7. Effect of α,β-dehydroalanine derivatives (Ala2, Ala3, Ala5 and Ala6) at IC50 
concentrations on mitochondrial transmembrane potential of AGS and  SH-SY5Y cells, 
evaluated by using the dual-emission potential-sensitive JC-1 probe. Results are 
expressed by ratio of red (aggregate) to green (monomer) fluorescence JC-1, and 
presented as mean ± standard error of mean (SEM) of three independent experiments, 
each one performed in triplicate. FCCP (250 nM) was used as positive control. 
Comparisons relative to the control were performed using one-way ANOVA with 
Bonferroni as post-test ***p < 0.001).  
 
 
